Related Experiment Videos
[Emergency endoscopic sclerosis in esophageal varices]
S Gallo Reynoso1, M Candelaria, J Elizondo Rivera
1Departamento de Endoscopia Gastrointestinal, Instituto Nacional de la Nutrición Salvador Zubirán, México, D.F.
Revista De Gastroenterologia De Mexico
|October 1, 1991
Summary
Endoscopic sclerotherapy effectively stops bleeding from esophageal varices in 93% of patients. However, this treatment does not improve long-term survival rates in patients with cirrhosis.
Area of Science:
- Gastroenterology
- Hepatology
- Endoscopic Procedures
Background:
- Esophageal varices are a common complication of advanced liver disease, posing a significant risk of life-threatening hemorrhage.
- Endoscopic interventions are crucial for managing acute variceal bleeding.
Purpose of the Study:
- To evaluate the efficacy and safety of endoscopic sclerotherapy in controlling active variceal bleeding.
- To assess the impact of endoscopic sclerotherapy on patient survival.
Main Methods:
- Endoscopic sclerotherapy was performed in 52 patients experiencing active variceal bleeding.
- Patient outcomes, including hemorrhage control, complications, and survival, were monitored.
Main Results:
- Hemorrhage was successfully stopped in 93% of patients treated with endoscopic sclerotherapy.
- The most common etiology was postnecrotic cirrhosis (50%), with a high proportion of Child 'C' patients (66%).
- Major complications included pleural effusion (2%) and mediastinal inflammation (2%); no treatment-related mortality was observed.
Conclusions:
- Endoscopic sclerotherapy is a valuable tool for the immediate control of variceal bleeding.
- The procedure does not appear to influence one-year survival rates in patients with cirrhosis.